drugset / Trial / NCT06781333

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

NCT06781333 ↗

Phase 2 Recruiting 8 enrolled Bernard (Barry) Baumel
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.

Timeline

Start
2025-04-29
Primary completion
2027-12-15
Completion
2027-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject hMSC Cell therapy 2.5e+07 cells Intravenous

Indications